Neuropsychopharmacology

Motivational Responses to Natural and Drug Rewards in Rats with Neonatal Ventral Hippocampal Lesions - An Animal Model of Dual Diagnosis Schizophrenia
pp. 889-905(17)
Authors: Chambers R.A.; Self D.W.

Homer 1a Gene Expression Modulation by Antipsychotic Drugs - Involvement of the Glutamate Metabotropic System and Effects of D-Cycloserine
pp. 906-913(8)
Authors: Polese D.; de Serpis A.A.; Ambesi-Impiombato A.; Muscettola G.; de Bartolomeis A.

Evaluation of Antidepressant-related Behavioral Responses in Mice Lacking the Serotonin Transporter
pp. 914-923(10)
Authors: Holmes A.; Yang R.J.; Murphy D.L.; Crawley J.N.

Conditioned Locomotion Is Not Correlated with Behavioral Sensitization to Cocaine - An Intra-Laboratory Multi-Sample Analysis
pp. 924-929(6)
Authors: Hotsenpiller G.; Wolf M.E.

The Effects of Excitotoxic Hippocampal Lesions in Rats on Risperidone- and Olanzapine-Induced Locomotor Suppression
pp. 930-938(9)
Authors: Bardgett M.E.; Humphrey W.M.; Csernansky J.G.

The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function
pp. 939-948(10)
Authors: Miller A.H.; Vogt G.J.; Pearce B.D.

R-fluoxetine Increases Extracellular DA, NE, As Well As 5-HT in Rat Prefrontal Cortex and Hypothalamus - An in vivo Microdialysis and Receptor Binding Study
pp. 949-959(11)
Authors: Koch S.; Perry K.W.; Nelson D.L.; Conway R.G.; Threlkeld P.G.; Bymaster F.P.

Gamma-hydroxybutyrate Reduces GABA_A-mediated Inhibitory Postsynaptic Potentials in the CA1 Region of Hippocampus
pp. 960-969(10)
Authors: Cammalleri M.; Brancucci A.; Berton F.; Loche A.; Gessa G.L.; Francesconi W.

Previous Exposure to VTA Amphetamine Enhances Cocaine Self-administration under a Progressive Ratio Schedule in a D₁ Dopamine Receptor Dependent Manner
pp. 970-979(10)
Authors: Suto N.; Austin J.D.; Tanabe L.M.; Kramer M.K.; Wright D.A.; Vezina P.

A Role for Electrotonic Coupling in the Striatum in the Expression of Dopamine Receptor-mediated Stereotypies
pp. 980-992(13)
Authors: Moore H.; Grace A.A.

Cognitive Performance of MDMA-Treated Rhesus Monkeys - Sensitivity to Serotonergic Challenge
pp. 993-1005(13)
Authors: Taffe M.A.; Davis S.A.; Yuan J.; Schroeder R.; Hatzidimitriou G.; Parsons L.H.; Ricaurte G.A.; Gold L.H.

Effect of Dopamine Receptor Antagonists on Renewal of Cocaine Seeking by Reexposure to Drug-associated Contextual Cues
pp. 1006-1015(10)
Authors: Crombag H.S.; Grimm J.W.; Shaham Y.

Effects of Rapid Tryptophan Depletion on Sleep Electroencephalogram and Mood in Subjects with Partially Remitted Depression on Bupropion
pp. 1016-1026(11)
Authors: Evans L.; Golshan S.; Kelsoe J.; Rapaport M.; Resovsky K.; Sutton L.; Gillin J.C.

Amphetamine-Induced Increases in Extracellular Dopamine, Drug Wanting, and Novelty Seeking - A PET/[¹¹C]Raclopride Study in Healthy Men
pp. 1027-1035(9)
Authors: Leyton M.; Boileau I.; Benkelfat C.; Diksic M.; Baker G.; Dagher A.

Dextroamphetamine Modulates the Response of the Human Amygdala
pp. 1036-1040(5)
Authors: Hariri A.R.; Mattay V.S.; Tessitore A.; Fera F.; Smith W.G.; Weinberger D.R.

Effects of the Neuropeptide Substance P on Sleep, Mood, and Neuroendocrine Measures in Healthy Young Men
pp. 1041-1049(9)
Authors: Lieb K.; Ahlvers K.; Dancker K.; Strohbusch S.; Reincke M.; Feige B.; Berger M.; Riemann D.; Voderholzer U.

Is the Time Course of Clozapine Response Correlated to the Time Course of Clozapine Plasma Levels? A One-Year Prospective Study in Drug-Resistant Patients with Schizophrenia
pp. 1050-1055(6)
Authors: Fabrazzo M.; La Pia S.; Monteleone P.; Esposito G.; Pinto A.; De Simone L.; Bencivenga R.; Maj M.

Nicotine and Behavioral Markers of Risk for Schizophrenia - A Double-Blind, Placebo-Controlled, Cross-Over Study
pp. 1056-1070(15)
Authors: Depatie L.; O'Driscoll G.A.; Holahan A.-L.V.; Atkinson V.; Thavundayil J.X.; Kin N.N.Y.; Lal S.

Amisulpride vs. Risperidone in Chronic Schizophrenia - Results of a 6-month Double-blind Study
pp. 1071-1081(11)
Authors: Sechter D.; Peuskens J.; Fleurot O.; Rein W.; Lecrubier Y.; the; Amisulpride Study Group

Are Differential Behavioral Responses to Smoking and Smoking Cessation in Schizophrenia Related to Nicotinic Receptor Levels?
pp. 1082-1083(2)
Authors: Leonard S.; Giordano L.

Roger M. Brown, 1941-2002
pp. 1086-1087(2)
Authors: Frascella J.; Pilotte N.; Thomas D.

Erratum - Dopamine D₂ and D₃ Receptor Occupancy in Normal Humans Treated with the Antipsychotic Drug Aripiprazole (OPC 14597): A Study Using Positron Emission Tomography and [¹¹C]Raclopride
pp. 1090-1090(1)

Erratum - SR46349-B, a 5-HT_2A/2C Receptor Antagonist, Potentiates Haloperidol-induced Dopamine Release in Rat Medial Prefrontal Cortex and Nucleus Accumbens
pp. 1091-1091(1)

Erratum - mRNA and Protein Expression of Selective Alpha Subunits of G Proteins are Abnormal in Prefrontal Cortex of Suicide Victims
pp. 1092-1092(1)

Author index volume 27
pp. 1093-1095(3)

Subject index volume 27
pp. 1096-1098(3)